KIT and gastrointestinal stromal tumor: A cohort of 47 samples with KIT mutations, consisting of 16 patients with advanced (high-risk) GIST and 31 with nonadvanced (low-risk and very low-risk) GIST, was used to screen the DEGs using GEO2R.